• Corpus ID: 26693573

Association for Research in Vision and Ophthalmology (ARVO)--2010 Annual Meeting. For Sight: The Future of Eye and Vision Research--part 2.

@article{Hookes2010AssociationFR,
  title={Association for Research in Vision and Ophthalmology (ARVO)--2010 Annual Meeting. For Sight: The Future of Eye and Vision Research--part 2.},
  author={Livia Hookes},
  journal={IDrugs : the investigational drugs journal},
  year={2010},
  volume={13 7},
  pages={
          430-2
        }
}
  • L. Hookes
  • Published 1 July 2010
  • Medicine
  • IDrugs : the investigational drugs journal
The 2010 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO), held in Fort Lauderdale, FL, USA, included topics covering new therapeutic developments in the field of eye and vision research. This conference report highlights selected presentations on the development of OT-440 (Othera Pharmaceuticals Inc) for the potential treatment of glaucoma, an extended-release implant of brimonidine (pSivida Corp) for ocular hypertension, AR-12286 (Aerie Pharmaceuticals Inc… 

Diabetic retinopathy: Breaking the barrier.

Ocular distribution of difluprednate ophthalmic emulsion 0.05% in rabbits.

  • T. TajikaA. IsowakiH. Sakaki
  • Medicine, Biology
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
  • 2011
TLDR
After instillation of tritium-labeled difluprednate ophthalmic emulsion 0.05% in rabbit eyes, radioactivity was distributed at the anterior segment and cleared rapidly and may be a potential treatment for ocular inflammation in these areas.

The assessment of the concentration of candidate cytokines in response to conjunctival-exposure of atmospheric low-temperature plasma in an animal model

TLDR
ALTP can probably be used as a minimally-invasive therapeutic method that triggers no permanent or continual inflammatory responses and might help the patients to shorten the consumption of immunosuppressive drugs after ALTP-surgery.